↓ Skip to main content

Immunosafety of Recombinant Human C1-Inhibitor in Hereditary Angioedema: Evaluation of IgE Antibodies

Overview of attention for article published in Clinical Drug Investigation, March 2013
Altmetric Badge

Mentioned by

facebook
1 Facebook page

Citations

dimensions_citation
16 Dimensions

Readers on

mendeley
19 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Immunosafety of Recombinant Human C1-Inhibitor in Hereditary Angioedema: Evaluation of IgE Antibodies
Published in
Clinical Drug Investigation, March 2013
DOI 10.1007/s40261-013-0064-2
Pubmed ID
Authors

C. Erik Hack, Anurag Relan, Aartie Baboeram, Beatrijs Oortwijn, Serge Versteeg, Ronald van Ree, Rienk Pijpstra

Abstract

Recombinant human C1-inhibitor (rhC1INH) purified from milk of transgenic rabbits is used for the treatment of acute attacks in patients with hereditary angioedema (HAE) due to C1-inhibitor (C1INH) deficiency.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 19 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 5%
Unknown 18 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 26%
Other 2 11%
Student > Master 2 11%
Student > Ph. D. Student 2 11%
Student > Doctoral Student 1 5%
Other 3 16%
Unknown 4 21%
Readers by discipline Count As %
Medicine and Dentistry 7 37%
Pharmacology, Toxicology and Pharmaceutical Science 2 11%
Agricultural and Biological Sciences 2 11%
Biochemistry, Genetics and Molecular Biology 1 5%
Psychology 1 5%
Other 1 5%
Unknown 5 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 March 2013.
All research outputs
#20,185,720
of 22,701,287 outputs
Outputs from Clinical Drug Investigation
#862
of 959 outputs
Outputs of similar age
#171,176
of 194,888 outputs
Outputs of similar age from Clinical Drug Investigation
#14
of 14 outputs
Altmetric has tracked 22,701,287 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 959 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.7. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 194,888 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.